BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2017

Feb 15, 2017

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2016-12-31

Reporting Person: Mueller Brian (SVP, Corporate Controller)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-10-31	Common Stock	A	62	$68.422	Acquired	14002	Direct

Footnotes

F1: Represents shares acquired by the reporting person on October 31, 2016, pursuant to the issuer's Employee Stock Purchase Plan.

F2: Amount of securities beneficially owned has been updated from the reporting person's prior report to exclude 320 shares inadvertently included in prior reports based on a reconciliation with the Company's records.